C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2699786
The present invention relates to the prediction of antipsychotic treatment efficacy based on a patient's genotype at one or more single nucleotide polymorphism (SNP) loci associated with iloperidone efficacy and to the treatment of a patient based on such prediction.
La présente invention concerne la prévision d'efficacité d'un traitement antipsychotique fondé sur un génotype de patient à un ou à plusieurs sites de polymorphisme d'un nucléotide simple (SNP) associé à l'efficacité de l'ilopéridone et, le traitement d'un patient fondé sur cette prévision.
Lavedan Christian
Licamele Louis
Polymeropoulos Mihael H.
Volpi Simona
Shapiro Cohen
Vanda Pharmaceuticals Inc.
LandOfFree
Antipsychotic treatment based on snp genotype does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antipsychotic treatment based on snp genotype, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antipsychotic treatment based on snp genotype will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1850166